| Literature DB >> 34918683 |
Julie Planchette1, Clara Jaccard1, Audrey Nigron2, Jean-Baptiste Chadeyras3, Guillaume Le Guenno4, Benjamin Castagne1, Yvan Jamilloux5, Anne-Sophie Resseguier1, Pascal Sève5,6.
Abstract
ABSTRACT: The transient occlusion of the terminal thoracic duct is a rare disease responsible for renitent supraclavicular cysts. The aim of this study was to describe the clinical characteristics, evolution, and treatment.A retrospective multicenter study and literature review was carried out. The literature search (PubMed) was conducted including data up to 31 December 2020 and PRISMA guidelines were respected.This study identified 6 observational cases between September 2010 and December 2020. The search results indicated a total of 24 articles of which 19 were excluded due to the lack of recurrent swelling or the unavailability of full texts (n = 5). Fourteen patients (8 from literature) mostly reported a noninflammatory, painless renitent mass in the supraclavicular fossa which appeared rapidly over a few hours and disappeared spontaneously over an average of 8 days (range: from about 2 hours to 10 days). Anamnesis indicated a high-fat intake during the preceding days in all cases and 7 from literature found in the Medline databases. Recurrences were noted in 10 patients. Thoracic duct imaging was performed in all cases to detect abnormalities or extrinsic compression as well as to eliminate differential diagnoses.A painless, fluctuating, noninflammatory, and recurrent swelling of the left supraclavicular fossa in patients evoking an intermittent obstruction of the terminal portion of the thoracic duct was identified. A low-fat diet was found as safe and effective treatment.Entities:
Mesh:
Year: 2021 PMID: 34918683 PMCID: PMC8678004 DOI: 10.1097/MD.0000000000028213
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 2Comparison between scannographic slides of observation 1 and a healthy patient showing obstruction and dilatation of the terminal portion of the thoracic duct with swelling around the dilatation.
Figure 3Ultrasonography sections of a patient in observation 1 (top) versus a healthy patient: dilated thoracic duct with holding an echogenic structure (thrombosis).
Figure 4Photos of patients in observation 4 and observation 5 showing the supraclavicular mass demonstrating the obstruction of the final portion of the thoracic duct.
Figure 1Study flow chart.
Overview of our cases and studies assessing patients with transient obstruction of the thoracic duct terminal portion.
| Studies | Sex | Age | Pathology duration | Episode duration | Recurrences | Complications | Trigger | Treatment | Follow up |
| Dendorfer et al[ | F | 33 | 3 yr | 5 d | Several | No | Fat/Alcohol | DI | No follow up |
| Veziant et al[ | F | 49 | 10 yr | 10 d | 2 over a 10-yr period | Chylothorax and Chyloperitonéum | Fat/Alcohol | DI then 10 yr after LVA | No reccurrences in 3 yr after LVA |
| Preyer et al[ | F | 36 | 2–3 mo | NK | Several | No | Clomiphène | Surgery | No |
| Preyer et al[ | F | 37 | 7 mo | NK | Several | No | COC | Surgery | 1 recurrence on the right side |
| Preyer et al[ | F | 48 | 10 yr | NK | Several | No | Estradiol valerate | Surgery | No |
| Preyer et al[ | F | 22 | Few weeks | 10 d | 2 | No | COC | Surgery | No |
| Zatterstrom et al[ | M | 55 | 24 yr | Few years | 0 | No | High fat diet | DI | 10 yr |
| Van Den Bussche et al[ | F | 83 | 1 mo | 1 wk | 1 | No | Hypertriglyceridemia | Puncture and DI | No |
| Observational study case 1 | M | 50 | 1 mo | 3 d | 1 | No | Fat | DI | No |
| Observational study case 2 | F | 74 | 1 yr | 1–2 d | 2 | No | Fat/Alcohol | DI | No |
| Observational study case 3 | F | 45 | 1 mo | 1 mo | 1 | Pain | Fat/Alcohol | DI | No reccurrences in 3 yr |
| Observational study case 4 | F | 65 | 7 yr | Few hours to few days | Several | No | NI | DI | No |
| Observational study case 5 | F | 64 | 10 yr | 1 d | 4 | Pain | Pregnancy, then NI | DI + LIPROCIL | 1 reccurence in 2 yr |
| Observational study case 6 | F | 62 | 3 wk | 3 wk | 2 | Chylothorax + Chyloperitoneum | Fat/alcohol | DI + Nutricia | No recurrence in 2 wk |
COC = combined oral contraceptive, DI = dietary intervention, LVA = lymphovenous anastomosis, NI = not identified, NK = not known.